Peapack-Gladstone Financial Corp’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,191
| Closed | -$587K | – | 708 |
|
|
2025
Q1 | $587K | Buy |
9,191
+75
| +0.8% | +$4.79K | 0.01% | 455 |
|
|
2024
Q4 | $1.11M | Hold |
9,116
| – | – | 0.02% | 378 |
|
|
2024
Q3 | $1.14M | Hold |
9,116
| – | – | 0.02% | 381 |
|
|
2024
Q2 | $1.44M | Hold |
9,116
| – | – | 0.02% | 358 |
|
|
2024
Q1 | $1.18M | Hold |
9,116
| – | – | 0.02% | 382 |
|
|
2023
Q4 | $879K | Hold |
9,116
| – | – | 0.01% | 410 |
|
|
2023
Q3 | $1.11M | Hold |
9,116
| – | – | 0.02% | 377 |
|
|
2023
Q2 | $1.04M | Buy |
9,116
+700
| +8% | +$80.2K | 0.02% | 386 |
|
|
2023
Q1 | $1.16M | Hold |
8,416
| – | – | 0.02% | 364 |
|
|
2022
Q4 | $1.09M | Hold |
8,416
| – | – | 0.02% | 359 |
|
|
2022
Q3 | $930K | Sell |
8,416
-3,300
| -28% | -$365K | 0.02% | 375 |
|
|
2022
Q2 | $878K | Sell |
11,716
-150
| -1% | -$11.2K | 0.02% | 369 |
|
|
2022
Q1 | $927K | Buy |
11,866
+566
| +5% | +$44.2K | 0.02% | 377 |
|
|
2021
Q4 | $1.02M | Sell |
11,300
-50
| -0.4% | -$4.5K | 0.02% | 383 |
|
|
2021
Q3 | $1.05M | Buy |
11,350
+350
| +3% | +$32.4K | 0.02% | 365 |
|
|
2021
Q2 | $855K | Buy |
11,000
+400
| +4% | +$31.1K | 0.02% | 360 |
|
|
2021
Q1 | $790K | Buy |
10,600
+2,350
| +28% | +$175K | 0.02% | 357 |
|
|
2020
Q4 | $1.41M | Buy |
+8,250
| New | +$1.41M | 0.04% | 229 |
|
|
2016
Q1 | – | Sell |
-5,700
| Closed | -$220K | – | 333 |
|
|
2015
Q4 | $220K | Buy |
+5,700
| New | +$220K | 0.02% | 314 |
|